bioRxivPathology
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues
F. Zakrzewski, W. de Back, M. Weigert, T. Wenke, S. Zeugner, R. Mantey, C. Sperling, K. Friedrich, I. Roeder, D. E. Aust, G. Baretton, P. Hoenscheid
Abstract
The human epidermal growth factor receptor 2 (HER2) gene amplification status is a crucial marker for evaluating clinical therapies of breast or gastric cancer. We propose a deep learning-based pipeline for the detection, localization and classification of interphase nuclei depending on their HER2 gene amplification state in Fluorescence in situ hybridization (FISH) images. Our pipeline combines two RetinaNet-based object localization networks which are trained (1) to detect and classify interphase nuclei into distinct classes normal, low-grade and high-grade and (2) to detect and classify FISH signals into distinct classes HER2 or centromere of chromosome 17 (CEN17). By independently classifying each nucleus twice, the two-step pipeline provides both robustness and interpretability for the automated detection of the HER2 amplification status. The accuracy of our deep learning-based pipeline is on par with that of three pathologists and FISH images on a set of 57 validation images containing several hundreds of nuclei are accurately classified. The automatic pipeline is a first step towards assisting pathologists in evaluating the HER2 status of tumors using FISH images, for analyzing FISH images in retrospective studies, and for optimizing the documentation of each tumor sample by automatically annotating and reporting of the HER2 gene amplification specificities.
- organism: human
- assay: imaging
- assay: fluorescence / live-cell microscopy
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predicting the HER2 status in esophageal cancer from tissue microarrays using convolutional neural networks
Juan I. Pisula, Rabi Raj Datta, … Katarzyna Bożek·bioRxiv·May 13, 2022
- Accurate Prediction of ecDNA in Interphase Cancer Cells using Deep Neural Networks
Utkrisht Rajkumar, Gino Prasad, … Vineet Bafna·bioRxiv·Jun 23, 2025
- Deep learning trained on H&E tumor ROIs predicts HER2 status and Trastuzumab treatment response in HER2+ breast cancer
Saman Farahmand, Aileen I. Fernandez, … Kourosh Zarringhalam·Modern PathologyPeer-reviewed·Sep 7, 2021
- HIGH-CONTENT, CELL-BY-CELL ASSESSMENT OF HER2 OVEREXPRESSION AND AMPLIFICATION FOR HETEROGENEITY DETECTION IN BREAST CANCER
H. T. Nguyen, D. Migliozzi, … M. A. M. Gijs·bioRxiv·Sep 17, 2018
- Validation of HER2 status in whole genome sequencing data of breast cancers with AI-driven, ploidy-corrected approach
Marzena Liliana Wojtaszewska, Rafał Stępień, … Paweł Zawadzki·Molecular Diagnosis & TherapyPeer-reviewed·Dec 21, 2021
- Development of a Deep Learning model Tailored for HER2 Detection in Breast Cancer to aid pathologists in interpreting HER2-Low cases
Pierre‐Antoine Bannier, Glenn Broeckx, … Sheeba Irshad·HistopathologyPeer-reviewed·Jul 14, 2024